15 results match your criteria: "King College Hospital[Affiliation]"

Incidence and epidemiology of aneurysmal subarachnoid haemorrhage in Australian Aboriginal and Torres Strait Islanders; a ten-year population study.

J Clin Neurosci

November 2023

Department of Neurosurgery, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW 2304, Australia; Department of Neurosurgery, King College Hospital, Bessemer Road, London SE5 9RS, United Kingdom.

Health disparity between Aboriginal and Torres Strait Islander (ATSI) Australians and non ATSI Australians is well established. Incidence and epidemiology of aneurysmal subarachnoid haemorrhage (aSAH) in the ATSI population is less well described. An observational, cross-sectional study was conducted to identify all acute spontaneous subarachnoid haemorrhage in the Hunter New England and Mid North Coast population of New South Wales, Australia.

View Article and Find Full Text PDF

Wound healing is a multiplex interaction process that involves extracellular matrix, blood vessels, proteases, cytokines, and chemokine. So far, a number of studies have been performed to understand the basis of the wound-healing process and multiple wound-healing products have been designed. However, significant morbidity and mortality incidents still occurred due to poor wound healing.

View Article and Find Full Text PDF

Background And Aims: Patients with liver disease acquire complex changes in their hemostatic system, resulting in prolongation of the international normalized ratio and thrombocytopenia. Abnormalities in these tests are commonly corrected with fresh frozen plasma (FFP) or platelet transfusions before invasive procedures. Whether these prophylactic transfusions are beneficial and truly indicated is increasingly debated.

View Article and Find Full Text PDF

Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery.

J Thromb Haemost

November 2020

Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Background: In vitro efficacy of pro- and antihemostatic drugs is profoundly different in patients with compensated cirrhosis and in those who have cirrhosis and are critically ill.

Objectives: Here we assessed the efficacy of pro- and anticoagulant drugs in plasma of patients undergoing hepato-pancreato-biliary (HPB) surgery, which is associated with unique hemostatic changes.

Methods: We performed in vitro analyses on blood samples of 60 patients undergoing HPB surgery and liver transplantation: 20 orthotopic liver transplantations, 20 partial hepatectomies, and 20 pylorus-preserving pancreaticoduodenectomies.

View Article and Find Full Text PDF

Eculizumab is first-line treatment for paroxysmal nocturnal hemoglobinuria (PNH); however, approximately 11%-27% of patients may experience breakthrough hemolysis (BTH) on approved doses of eculizumab. Ravulizumab, a new long-acting C5 inhibitor with a four-times longer mean half-life than eculizumab, provides immediate, complete, and sustained C5 inhibition over 8-week dosing intervals. In two phase 3 studies, ravulizumab was noninferior to eculizumab (Pinf ≤0.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how liver diseases alter blood coagulation, leading to both bleeding and clotting issues in patients, even when their overall haemostatic system is "rebalanced."
  • Researchers tested various pro- and antihaemostatic treatments in lab conditions using plasma from healthy individuals and patients with different stages of liver disease.
  • Results showed that while some treatments had limited effects, prothrombin complex concentrate and fibrinogen concentrate significantly improved blood clotting, highlighting the need for adjusted doses of anticoagulants in these patients.
View Article and Find Full Text PDF

Background: Cirrhotic patients have complex haemostatic abnormalities. Current evidence suggests stable cirrhotic (SC) patients have a "re-balanced" haemostatic state. However, limited data exists in acute decompensated (AD) or acute on chronic liver failure (ACLF) patients.

View Article and Find Full Text PDF

We describe a patient presenting with incessant ectopic atrial tachycardia during a high risk twin pregnancy. Tachycardia was resistant to escalating doses of beta-blockade with digoxin. Because of increasing left ventricular dysfunction early in the third trimester, catheter ablation was performed successfully at 30 weeks gestation.

View Article and Find Full Text PDF

The performances of two generations of computed radiography (CR) were tested and compared in terms of resolution and noise characteristics. The main aim was to characterize and quantify the noise sources in the images. The systems tested were (1) Agfa CR 25.

View Article and Find Full Text PDF

We report a case of a 6-year-old girl of Afro-Caribbean origin, known to have sickle cell disease (SCD), with recurrent history of jaundice and abdominal pain. She was extensively investigated, including endoscopic retrograde cholangiopancreatography (ERCP), which revealed diffuse cholangiopathy of both extrahepatic and intrahepatic bile ducts. A pigtail stent was placed and balloon dilatation was performed for stricture of the extrahepatic duct.

View Article and Find Full Text PDF

Antimitochondrial and other autoantibodies.

Clin Liver Dis

November 2003

Institute of Liver Studies, King College Hospital, Denmark Hill Campus, London SE5 9RS, UK.

Primary biliary cirrhosis (PBC) is characterized by the presence of high-titer disease specific autoantibodies directed against mitochondrial antigens (AMA) of the inner mitochondrial membrane, that are members of the 2-oxo acid complex. Among numerous other autoantibodies found in PBC the focus of ongoing studies is on the PBC-specific anti-nuclear antibodies, that are of diagnostic and clinical relevance since they can be used as a 'positive tool' in the diagnosis of AMA-negative PBC while at the same time identifying a subgroup of patients with more advanced liver disease.

View Article and Find Full Text PDF